FDA Clears Epithelial Thickness Mapping for Cirrus Platform

The FDA granted 510(k) clearance to Carl Zeiss Meditec’s for inclusion of epithelial thickness mapping in its Cirrus HD-OCT platform, which offers solutions for various ophthalmic practices.

The device can perform optical coherence tomography (OCT), a non-invasive imaging test that uses light waves to take pictures of a patient’s retina.

The device’s new module helps identify patients eligible for refractive surgery and monitors how the cornea responds to post-surgical healing.